These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2142674)

  • 1. Immunomodulatory properties of platelet factor 4: prevention of concanavalin A suppressor-induction in vitro and augmentation of an antigen-specific delayed-type hypersensitivity response in vivo.
    Gregg EO; Yarwood L; Wagstaffe MJ; Pepper DS; Macdonald MC
    Immunology; 1990 Jun; 70(2):230-4. PubMed ID: 2142674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isotype-like suppression of T cell-mediated immunity in vivo. I. Delayed-type hypersensitivity specificity of T cell suppression induced by antigen-binding T cell factors that initiate contact sensitivity.
    Ptak W; Bereta M; Ptak M; Askenase PW
    J Immunol; 1986 Mar; 136(5):1554-63. PubMed ID: 2419404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the T suppressor circuit of delayed-type hypersensitivity by interferon.
    Knop J; Stremmer R; Taborski U; Freitag W; de Maeyer-Guignard J; Macher E
    J Immunol; 1984 Nov; 133(5):2412-6. PubMed ID: 6237149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of 2'-deoxyguanosine upon the development of DTH effector T cells and suppressor T cells in vivo.
    Bril H; van den Akker TW; Molendijk-Lok BD; Bianchi AT; Benner R
    J Immunol; 1984 Feb; 132(2):599-604. PubMed ID: 6228591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the antigen-reactive T cell line mediating in vivo delayed type hypersensitivity established by antigen-induced interleukin 2.
    Kobayashi K; Cohen S; Yoshida T
    J Exp Pathol; 1989; 4(3):163-79. PubMed ID: 2788724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of inhibitory activity for B cell differentiation in human CD8 T cells with pokeweed mitogen, dimaprit, and cAMP upregulating agents: countersuppressive effect of platelet factor 4.
    Crisi GM; Katz IR; Zucker MB; Thorbecke GJ
    Cell Immunol; 1996 Sep; 172(2):205-16. PubMed ID: 8964082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo analysis of a superantigen-induced T cell suppressor factor.
    Hu HL; Cornwell WD; Rogers TJ; Lin YS
    Cell Immunol; 1996 Feb; 167(2):285-92. PubMed ID: 8603438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell responses induced by the parenteral injection of antigen-modified syngeneic cells. I. Induction, characterization, and regulation of antigen-specific T helper cells involved in delayed-type hypersensitivity responses.
    Miller SD; Butler LD
    J Immunol; 1983 Jul; 131(1):77-85. PubMed ID: 6190929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressor T cell circuits in contact sensitivity. II. Induction and characterization of an efferent-acting, antigen-specific, H-2-restricted, monoclonal T cell hybrid-derived suppressor factor specific for DNFB contact hypersensitivity.
    Miller SD
    J Immunol; 1984 Dec; 133(6):3112-20. PubMed ID: 6208271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoregulatory pathways in adult responder mice. III. Establishment of a GAT-specific suppressor T cell clone from GAT-tolerant responders which afferently regulates DTH responses.
    Jenkins MK; Miller SD
    J Mol Cell Immunol; 1985; 2(1):1-13. PubMed ID: 2978221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of febrile temperatures on biologic actions of interferons: abrogation of suppression of delayed-type hypersensitivity and antibody production.
    Ron Y; Dougherty JP; Duff GW; Gershon RK
    J Immunol; 1984 Oct; 133(4):2037-42. PubMed ID: 6206148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of suppressed cell-mediated immunity and impaired antigen-induced interleukin 2 production in granuloma-bearing mice.
    Kobayashi K; Allred C; Yoshida T
    J Immunol; 1985 Nov; 135(5):2996-3003. PubMed ID: 2931477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of arecoline on immune system: II. Suppression of thymus-dependent immune responses and parameter of non-specific resistance after short-term exposure.
    Selvan RS; Selvakumaran M; Rao AR
    Immunopharmacol Immunotoxicol; 1991; 13(3):281-309. PubMed ID: 1940050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of in vivo regulatory properties of T cells activated in vitro by TGFbeta2-treated antigen presenting cells.
    Kezuka T; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1410-21. PubMed ID: 10798657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of delayed-type hypersensitivity. VI. Antigen-specific suppressor T cells and suppressor factor for delayed-type hypersensitivity to histocompatibility antigens.
    Liew FY
    Transplantation; 1982 Jan; 33(1):69-76. PubMed ID: 6461112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
    Peeler JS; Niederkorn JY
    J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmentation of delayed-type hypersensitivity to high dose sheep erythrocytes by cyclosporin A in the mouse: influence of drug dosage and route of administration and analysis of spleen cell populations.
    Webster LM; Thomson AW
    Clin Exp Immunol; 1988 Jan; 71(1):149-54. PubMed ID: 3349644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo activated OVA specific and non-specific CD4+CD25+ regulatory T cells exhibit comparable suppression to OVA mediated T cell responses.
    Li J; Bracht M; Shang X; Radewonuk J; Emmell E; Griswold DE; Li L
    Cell Immunol; 2006 Jun; 241(2):75-84. PubMed ID: 17010326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of antigen-specific T cell responses by Leishmania major excreted factor: inhibition of activation signals linked to the T cell antigen receptor and interleukin 2 receptor.
    Isakov N; Tamir A; el-On J
    Isr J Med Sci; 1994 Sep; 30(9):673-9. PubMed ID: 8088978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of suppressor-cell activity by cyclophosphamide in patients with malignant melanoma.
    Livingston PO; Cunningham-Rundles S; Marfleet G; Gnecco C; Wong GY; Schiffman G; Enker WE; Hoffman MK
    J Biol Response Mod; 1987 Aug; 6(4):392-403. PubMed ID: 2957470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.